Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria: a case study on Alzheimer's Disease and Donepezil.
Qian LiYi GuoZhe HeHansi ZhangThomas J. GeorgeJiang BianPublished in: AMIA (2020)
Keyphrases
- clinical trials
- multiple sclerosis
- disease progression
- cancer patients
- decision support system
- clinical practice
- mild cognitive impairment
- medical practice
- breast cancer patients
- computer aided diagnosis
- clinical guidelines
- experimental design
- lesion segmentation
- early diagnosis
- computer aided
- artificial intelligence
- data sources